Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Mereo BioPharma Group plc (MREO)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.4300+0.0300 (+2.14%)
At close: 04:00PM EST
1.4700 +0.04 (+2.80%)
After hours: 05:48PM EST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 1.49
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 34.7110
52 Week Low 31.2700
50-Day Moving Average 31.7778
200-Day Moving Average 32.6002

Share Statistics

Avg Vol (3 month) 3870.63k
Avg Vol (10 day) 3727.55k
Shares Outstanding 5108.9M
Implied Shares Outstanding 6N/A
Float 837.46M
% Held by Insiders 10.24%
% Held by Institutions 182.71%
Shares Short (Dec 14, 2021) 45.47M
Short Ratio (Dec 14, 2021) 44.97
Short % of Float (Dec 14, 2021) 4N/A
Short % of Shares Outstanding (Dec 14, 2021) 45.02%
Shares Short (prior month Nov 14, 2021) 410.08M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in GBP.

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Jun 29, 2021

Profitability

Profit Margin -73.83%
Operating Margin (ttm)-57.82%

Management Effectiveness

Return on Assets (ttm)-10.35%
Return on Equity (ttm)-51.32%

Income Statement

Revenue (ttm)36.46M
Revenue Per Share (ttm)0.35
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -22.01M
Net Income Avi to Common (ttm)-26.92M
Diluted EPS (ttm)-0.3560
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)110.09M
Total Cash Per Share (mrq)1.11
Total Debt (mrq)20.61M
Total Debt/Equity (mrq)25.54
Current Ratio (mrq)12.19
Book Value Per Share (mrq)0.82

Cash Flow Statement

Operating Cash Flow (ttm)-7.28M
Levered Free Cash Flow (ttm)-12.88M
Advertisement
Advertisement